Search by Drug Name or NDC
NDC 60505-6237-06 Deferoxamine mesylate 2 g/1 Details
Deferoxamine mesylate 2 g/1
Deferoxamine mesylate is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is DEFEROXAMINE MESYLATE.
Product Information
| NDC | 60505-6237 |
|---|---|
| Product ID | 60505-6237_056c4911-ada8-d21c-cfc2-db538c573a21 |
| Associated GPIs | 93000020102130 |
| GCN Sequence Number | 015181 |
| GCN Sequence Number Description | deferoxamine mesylate VIAL 2 G INJECTION |
| HIC3 | C8A |
| HIC3 Description | METALLIC POISON,AGENTS TO TREAT |
| GCN | 07112 |
| HICL Sequence Number | 001104 |
| HICL Sequence Number Description | DEFEROXAMINE MESYLATE |
| Brand/Generic | Generic |
| Proprietary Name | Deferoxamine mesylate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Deferoxamine mesylate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | g/1 |
| Substance Name | DEFEROXAMINE MESYLATE |
| Labeler Name | Apotex Corp. |
| Pharmaceutical Class | Iron Chelating Activity [MoA], Iron Chelator [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207384 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 60505-6237-06 (60505623706)
| NDC Package Code | 60505-6237-6 |
|---|---|
| Billing NDC | 60505623706 |
| Package | 4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (60505-6237-6) |
| Marketing Start Date | 2021-11-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |